Table 2.

Mean INR/Cp values and warfarin daily dose in various genotypes determined from single and multiple gene polymorphisms


Gene

Allele

Genotype

n

INR/Cp

Warfarin dose, mg (range)
Factor II  494C (M1) M1/M1  8   2.62 ± 0.54   3.3 ± 1.1 (1.5-5.0)  
 494T (M2) M1/M2  18   3.00 ± 0.39   3.9 ± 1.8 (1.5-7.5)  
  M2/M2  19   3.26 ± 0.18*  3.8 ± 2.1 (1.0-8.5)  
Factor VII  402G (B1) B1/B1  14   3.42 ± 0.82   3.5 ± 2.0 (1.5-8.0)  
 402A (B2) B1/B2  22   3.09 ± 0.43  3.9 ± 1.9 (1.0-8.5)  
  B2/B2  9   2.39 ± 0.18*  3.8 ± 1.3 (1.5-6.0)  
 (37-bp repeat)6 (a) a/a  36   3.14 ± 0.55   3.8 ± 1.9 (1.0-8.5)  
 (37-bp repeat)7 (b) b/b  9   2.58 ± 0.21   3.5 ± 1.3 (1.5-5.0)  
 746T (N1) N1/N1  16   3.34 ± 0.66   3.6 ± 1.9 (1.5-8.0)  
 746C (N2) N1/N2  20   3.00 ± 0.51   4.0 ± 2.0 (1.0-8.5)  
  N2/N2  9   2.58 ± 0.21*  4.0 ± 1.3 (1.5-5.0)  
Combination   I  (M1/M1)(B2/B2)(b/b)(N2/N2)  5   2.14 ± 0.31   3.6 ± 1.4 (1.5-5.0)  
  II  (M1/M2)(B1/B1)(a/a)(N1/N1)  7   3.56 ± 0.41   3.0 ± 1.3 (1.5-4.5)  
  III  (M1/M2)(B1/B2)(a/a)(N1/N2)  3   2.63 ± 0.72   5.3 ± 2.6 (2.5-7.5)  
  IV  (M2/M2)(B1/B1)(a/a)(N1/N1)  3   4.48 ± 0.83   2.3 ± 1.4 (1.5-4.0)  

 
V
 
(M2/M2)(B1/B2)(a/a)(N1/N2)
 
9
 
2.93 ± 0.41
 
4.3 ± 1.9 (2.5-8.5)
 

Gene

Allele

Genotype

n

INR/Cp

Warfarin dose, mg (range)
Factor II  494C (M1) M1/M1  8   2.62 ± 0.54   3.3 ± 1.1 (1.5-5.0)  
 494T (M2) M1/M2  18   3.00 ± 0.39   3.9 ± 1.8 (1.5-7.5)  
  M2/M2  19   3.26 ± 0.18*  3.8 ± 2.1 (1.0-8.5)  
Factor VII  402G (B1) B1/B1  14   3.42 ± 0.82   3.5 ± 2.0 (1.5-8.0)  
 402A (B2) B1/B2  22   3.09 ± 0.43  3.9 ± 1.9 (1.0-8.5)  
  B2/B2  9   2.39 ± 0.18*  3.8 ± 1.3 (1.5-6.0)  
 (37-bp repeat)6 (a) a/a  36   3.14 ± 0.55   3.8 ± 1.9 (1.0-8.5)  
 (37-bp repeat)7 (b) b/b  9   2.58 ± 0.21   3.5 ± 1.3 (1.5-5.0)  
 746T (N1) N1/N1  16   3.34 ± 0.66   3.6 ± 1.9 (1.5-8.0)  
 746C (N2) N1/N2  20   3.00 ± 0.51   4.0 ± 2.0 (1.0-8.5)  
  N2/N2  9   2.58 ± 0.21*  4.0 ± 1.3 (1.5-5.0)  
Combination   I  (M1/M1)(B2/B2)(b/b)(N2/N2)  5   2.14 ± 0.31   3.6 ± 1.4 (1.5-5.0)  
  II  (M1/M2)(B1/B1)(a/a)(N1/N1)  7   3.56 ± 0.41   3.0 ± 1.3 (1.5-4.5)  
  III  (M1/M2)(B1/B2)(a/a)(N1/N2)  3   2.63 ± 0.72   5.3 ± 2.6 (2.5-7.5)  
  IV  (M2/M2)(B1/B1)(a/a)(N1/N1)  3   4.48 ± 0.83   2.3 ± 1.4 (1.5-4.0)  

 
V
 
(M2/M2)(B1/B2)(a/a)(N1/N2)
 
9
 
2.93 ± 0.41
 
4.3 ± 1.9 (2.5-8.5)
 

Other genotypes of patients in groups I through V were fixed as follows: CYP2C9*1/*1, haplotype A1 in the factor VII gene, and (CAA repeat)10 or 11 in the GGC gene.

*

P < .05 versus homozygotes for the reference allele

P < .05 versus homozygotes for the mutant allele

or Create an Account

Close Modal
Close Modal